Results 231 to 240 of about 82,660 (245)

Retinoic Acid and Arsenic Trioxide for Acute Promyelocytic Leukemia

New England Journal of Medicine, 2013
Giuseppe Avvisati, Marco Vignetti, Christian Thiede   +2 more
exaly  

Treatment of first relapse in acute promyelocytic leukaemia with all-trans retinoic acid

Lancet, The, 1990
Christine Chomienne
exaly  

All Trans Retinoic Acid and Cancer

Immunopharmacology and Immunotoxicology, 2011
V.M. Berlin Grace
exaly  

Preparation and characterization of micelles of oligomeric chitosan linked to all-trans retinoic acid

Carbohydrate Polymers, 2012
Ali Fattahi, Jaleh Varshosaz, Mohammadhossein Fathi   +2 more
exaly  

Active Pin1 is a key target of all-trans retinoic acid in acute promyelocytic leukemia and breast cancer

Nature Medicine, 2015
Shuo Wei, Shingo Kozono, jlenia guarnerio   +2 more
exaly  

Retinoic acid syndrome after the first dose of all-trans retinoic acid

All-trans retinoic acid (ATRA) was firstly used as a differentiating agent in 1987 in Shanghai for the treatment of acute promyelocytic leukemia (APL). Retinoic Acid Syndrome (RAS) became an important complication of therapy after the administration of ATRA. The frequency of syndrome is 27% and the precise cause is not entirely known.
Altintaş A., Paşa S., Ağgil C., Tural B., Ayyildiz O.   +4 more
openaire   +1 more source

Arsenic trioxide and all-trans retinoic acid treatment for acute promyelocytic leukaemia in all risk groups (AML17): results of a randomised, controlled, phase 3 trial

Lancet Oncology, The, 2015
Nigel H Russell, Robert K Hills, Jonathan Kell   +2 more
exaly  

9-cis retinoic acid is a high affinity ligand for the retinoid X receptor

Cell, 1992
David J Mangelsdorf
exaly  

Mechanisms of retinoic acid signalling and its roles in organ and limb development

Nature Reviews Molecular Cell Biology, 2015
Thomas J Cunningham, Gregg Duester
exaly  

Restoration of all-trans retinoic acid sensitivity by interferon in acute promyelocytic leukaemia

Lancet, The, 1991
exaly